Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics

Purpose To investigate the feasibility of reducing the acquisition time for continuous dynamic positron emission tomography (PET) while retaining acceptable performance in quantifying kinetic metrics of 2-[ 18 F]-fluoro-2-deoxy-D-glucose ([ 18 F]FDG) in tumors. Methods In total, 78 oncological patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nuclear medicine and molecular imaging 2024-04, Vol.51 (5), p.1371-1382
Hauptverfasser: Liu, Guobing, Shi, Yimeng, Hou, Xiaoguang, Yu, Haojun, Hu, Yan, Zhang, Yiqiu, Shi, Hongcheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1382
container_issue 5
container_start_page 1371
container_title European journal of nuclear medicine and molecular imaging
container_volume 51
creator Liu, Guobing
Shi, Yimeng
Hou, Xiaoguang
Yu, Haojun
Hu, Yan
Zhang, Yiqiu
Shi, Hongcheng
description Purpose To investigate the feasibility of reducing the acquisition time for continuous dynamic positron emission tomography (PET) while retaining acceptable performance in quantifying kinetic metrics of 2-[ 18 F]-fluoro-2-deoxy-D-glucose ([ 18 F]FDG) in tumors. Methods In total, 78 oncological patients underwent total-body dynamic PET imaging for ≥ 60 min, with 8, 20, and 50 patients receiving full activity (3.7 MBq/kg), half activity (1.85 MBq/kg), and ultra-low activity (0.37 MBq/kg) of [ 18 F]FDG, respectively. The dynamic data were divided into 21-, 30-, 45- and ≥ 60-min groups. The kinetic analysis involved model fitting to derive constant rates ( V B , K 1 to k 3 , and Ki ) for both tumors and normal tissues, using both reversible and irreversible two-tissue-compartment models. One-way ANOVA with repeated measures or the Freidman test compared the kinetic metrics among groups, while the Deming regression assessed the correlation of kinetic metrics among groups. Results All kinetic metrics in the 30-min and 45-min groups were statistically comparable to those in the ≥ 60-min group. The relative differences between the 30-min and ≥ 60-min groups ranged from 12.3% ± 15.1% for K 1 to 29.8% ± 30.0% for V B , and those between the 45-min and ≥ 60-min groups ranged from 7.5% ± 8.7% for Ki to 24.0% ± 24.3% for V B . However, this comparability was not observed between the 21-min and ≥ 60-min groups. The significance trend of these comparisons remained consistent across different models (reversible or irreversible), administrated activity levels, and partial volume corrections for lesions. Significant correlations in tumor kinetic metrics were identified between the 30-/45-min and ≥ 60-min groups, with Deming regression slopes > 0.813. In addition, the comparability of kinetic metrics between the 30-min and ≥ 60-min groups were established for normal tissues. Conclusion The acquisition time for dynamic PET imaging can be reduced to 30 min without compromising the ability to reveal tumor kinetic metrics of [ 18 F]FDG, using the total-body PET/CT system.
doi_str_mv 10.1007/s00259-023-06526-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2972958058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2972958058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-12697bf4540326343ed0233cbafd1e397e09a6cd9cc7b247ea5d5206fc8cde873</originalsourceid><addsrcrecordid>eNp9UctuEzEUtRCIlsIPsECWWA_1Y2ZsL1HaFKRK7SJdVcjy2HdSl4yd2B5V-Qs-GdO0ZdfVta7P4-ochD5T8o0SIk4zIaxTDWG8IX3H-qZ9g45pT1UjiFRvX96CHKEPOd8TQiWT6j064pIIqTpyjP6c7YOZvMUlFrNphuj2-Pp8dbpYYT-ZtQ9r_ODLHU7gZgsOG7ubffbFx4CLnwDnu_iQ69rCtphhA3gLaYxpMsEC9gHvZhOKH701j5w44lsql7-WZxe4zFNM-LcPUOoBE5Tkbf6I3o1mk-HT0zxBN8vz1eJHc3l18XPx_bKxTPHSUNYrMYxt1xLOet5ycDUHbgczOgpcCSDK9NYpa8XAWgGmcx0j_WildSAFP0FfD7rbFHcz5KLv45xCtdRMCaY6STpZUeyAsinmnGDU21RzSXtNif5Xgj6UoKu5fixBt5X05Ul6HiZwL5Tn1CuAHwC5foU1pP_er8j-BfjwlA8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2972958058</pqid></control><display><type>article</type><title>Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Liu, Guobing ; Shi, Yimeng ; Hou, Xiaoguang ; Yu, Haojun ; Hu, Yan ; Zhang, Yiqiu ; Shi, Hongcheng</creator><creatorcontrib>Liu, Guobing ; Shi, Yimeng ; Hou, Xiaoguang ; Yu, Haojun ; Hu, Yan ; Zhang, Yiqiu ; Shi, Hongcheng</creatorcontrib><description>Purpose To investigate the feasibility of reducing the acquisition time for continuous dynamic positron emission tomography (PET) while retaining acceptable performance in quantifying kinetic metrics of 2-[ 18 F]-fluoro-2-deoxy-D-glucose ([ 18 F]FDG) in tumors. Methods In total, 78 oncological patients underwent total-body dynamic PET imaging for ≥ 60 min, with 8, 20, and 50 patients receiving full activity (3.7 MBq/kg), half activity (1.85 MBq/kg), and ultra-low activity (0.37 MBq/kg) of [ 18 F]FDG, respectively. The dynamic data were divided into 21-, 30-, 45- and ≥ 60-min groups. The kinetic analysis involved model fitting to derive constant rates ( V B , K 1 to k 3 , and Ki ) for both tumors and normal tissues, using both reversible and irreversible two-tissue-compartment models. One-way ANOVA with repeated measures or the Freidman test compared the kinetic metrics among groups, while the Deming regression assessed the correlation of kinetic metrics among groups. Results All kinetic metrics in the 30-min and 45-min groups were statistically comparable to those in the ≥ 60-min group. The relative differences between the 30-min and ≥ 60-min groups ranged from 12.3% ± 15.1% for K 1 to 29.8% ± 30.0% for V B , and those between the 45-min and ≥ 60-min groups ranged from 7.5% ± 8.7% for Ki to 24.0% ± 24.3% for V B . However, this comparability was not observed between the 21-min and ≥ 60-min groups. The significance trend of these comparisons remained consistent across different models (reversible or irreversible), administrated activity levels, and partial volume corrections for lesions. Significant correlations in tumor kinetic metrics were identified between the 30-/45-min and ≥ 60-min groups, with Deming regression slopes &gt; 0.813. In addition, the comparability of kinetic metrics between the 30-min and ≥ 60-min groups were established for normal tissues. Conclusion The acquisition time for dynamic PET imaging can be reduced to 30 min without compromising the ability to reveal tumor kinetic metrics of [ 18 F]FDG, using the total-body PET/CT system.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-023-06526-4</identifier><identifier>PMID: 38078950</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cardiology ; Computed tomography ; Fluorine isotopes ; Fluorodeoxyglucose F18 ; Glucose ; Humans ; Imaging ; Kinetics ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Neoplasms - diagnostic imaging ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Positron emission ; Positron emission tomography ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography - methods ; Radiology ; Tumors</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2024-04, Vol.51 (5), p.1371-1382</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c293t-12697bf4540326343ed0233cbafd1e397e09a6cd9cc7b247ea5d5206fc8cde873</cites><orcidid>0000-0001-7457-876X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-023-06526-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-023-06526-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38078950$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Guobing</creatorcontrib><creatorcontrib>Shi, Yimeng</creatorcontrib><creatorcontrib>Hou, Xiaoguang</creatorcontrib><creatorcontrib>Yu, Haojun</creatorcontrib><creatorcontrib>Hu, Yan</creatorcontrib><creatorcontrib>Zhang, Yiqiu</creatorcontrib><creatorcontrib>Shi, Hongcheng</creatorcontrib><title>Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Purpose To investigate the feasibility of reducing the acquisition time for continuous dynamic positron emission tomography (PET) while retaining acceptable performance in quantifying kinetic metrics of 2-[ 18 F]-fluoro-2-deoxy-D-glucose ([ 18 F]FDG) in tumors. Methods In total, 78 oncological patients underwent total-body dynamic PET imaging for ≥ 60 min, with 8, 20, and 50 patients receiving full activity (3.7 MBq/kg), half activity (1.85 MBq/kg), and ultra-low activity (0.37 MBq/kg) of [ 18 F]FDG, respectively. The dynamic data were divided into 21-, 30-, 45- and ≥ 60-min groups. The kinetic analysis involved model fitting to derive constant rates ( V B , K 1 to k 3 , and Ki ) for both tumors and normal tissues, using both reversible and irreversible two-tissue-compartment models. One-way ANOVA with repeated measures or the Freidman test compared the kinetic metrics among groups, while the Deming regression assessed the correlation of kinetic metrics among groups. Results All kinetic metrics in the 30-min and 45-min groups were statistically comparable to those in the ≥ 60-min group. The relative differences between the 30-min and ≥ 60-min groups ranged from 12.3% ± 15.1% for K 1 to 29.8% ± 30.0% for V B , and those between the 45-min and ≥ 60-min groups ranged from 7.5% ± 8.7% for Ki to 24.0% ± 24.3% for V B . However, this comparability was not observed between the 21-min and ≥ 60-min groups. The significance trend of these comparisons remained consistent across different models (reversible or irreversible), administrated activity levels, and partial volume corrections for lesions. Significant correlations in tumor kinetic metrics were identified between the 30-/45-min and ≥ 60-min groups, with Deming regression slopes &gt; 0.813. In addition, the comparability of kinetic metrics between the 30-min and ≥ 60-min groups were established for normal tissues. Conclusion The acquisition time for dynamic PET imaging can be reduced to 30 min without compromising the ability to reveal tumor kinetic metrics of [ 18 F]FDG, using the total-body PET/CT system.</description><subject>Cardiology</subject><subject>Computed tomography</subject><subject>Fluorine isotopes</subject><subject>Fluorodeoxyglucose F18</subject><subject>Glucose</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kinetics</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neoplasms - diagnostic imaging</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiology</subject><subject>Tumors</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuEzEUtRCIlsIPsECWWA_1Y2ZsL1HaFKRK7SJdVcjy2HdSl4yd2B5V-Qs-GdO0ZdfVta7P4-ochD5T8o0SIk4zIaxTDWG8IX3H-qZ9g45pT1UjiFRvX96CHKEPOd8TQiWT6j064pIIqTpyjP6c7YOZvMUlFrNphuj2-Pp8dbpYYT-ZtQ9r_ODLHU7gZgsOG7ubffbFx4CLnwDnu_iQ69rCtphhA3gLaYxpMsEC9gHvZhOKH701j5w44lsql7-WZxe4zFNM-LcPUOoBE5Tkbf6I3o1mk-HT0zxBN8vz1eJHc3l18XPx_bKxTPHSUNYrMYxt1xLOet5ycDUHbgczOgpcCSDK9NYpa8XAWgGmcx0j_WildSAFP0FfD7rbFHcz5KLv45xCtdRMCaY6STpZUeyAsinmnGDU21RzSXtNif5Xgj6UoKu5fixBt5X05Ul6HiZwL5Tn1CuAHwC5foU1pP_er8j-BfjwlA8</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Liu, Guobing</creator><creator>Shi, Yimeng</creator><creator>Hou, Xiaoguang</creator><creator>Yu, Haojun</creator><creator>Hu, Yan</creator><creator>Zhang, Yiqiu</creator><creator>Shi, Hongcheng</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><orcidid>https://orcid.org/0000-0001-7457-876X</orcidid></search><sort><creationdate>20240401</creationdate><title>Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics</title><author>Liu, Guobing ; Shi, Yimeng ; Hou, Xiaoguang ; Yu, Haojun ; Hu, Yan ; Zhang, Yiqiu ; Shi, Hongcheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-12697bf4540326343ed0233cbafd1e397e09a6cd9cc7b247ea5d5206fc8cde873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cardiology</topic><topic>Computed tomography</topic><topic>Fluorine isotopes</topic><topic>Fluorodeoxyglucose F18</topic><topic>Glucose</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kinetics</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neoplasms - diagnostic imaging</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Guobing</creatorcontrib><creatorcontrib>Shi, Yimeng</creatorcontrib><creatorcontrib>Hou, Xiaoguang</creatorcontrib><creatorcontrib>Yu, Haojun</creatorcontrib><creatorcontrib>Hu, Yan</creatorcontrib><creatorcontrib>Zhang, Yiqiu</creatorcontrib><creatorcontrib>Shi, Hongcheng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Guobing</au><au>Shi, Yimeng</au><au>Hou, Xiaoguang</au><au>Yu, Haojun</au><au>Hu, Yan</au><au>Zhang, Yiqiu</au><au>Shi, Hongcheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>51</volume><issue>5</issue><spage>1371</spage><epage>1382</epage><pages>1371-1382</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Purpose To investigate the feasibility of reducing the acquisition time for continuous dynamic positron emission tomography (PET) while retaining acceptable performance in quantifying kinetic metrics of 2-[ 18 F]-fluoro-2-deoxy-D-glucose ([ 18 F]FDG) in tumors. Methods In total, 78 oncological patients underwent total-body dynamic PET imaging for ≥ 60 min, with 8, 20, and 50 patients receiving full activity (3.7 MBq/kg), half activity (1.85 MBq/kg), and ultra-low activity (0.37 MBq/kg) of [ 18 F]FDG, respectively. The dynamic data were divided into 21-, 30-, 45- and ≥ 60-min groups. The kinetic analysis involved model fitting to derive constant rates ( V B , K 1 to k 3 , and Ki ) for both tumors and normal tissues, using both reversible and irreversible two-tissue-compartment models. One-way ANOVA with repeated measures or the Freidman test compared the kinetic metrics among groups, while the Deming regression assessed the correlation of kinetic metrics among groups. Results All kinetic metrics in the 30-min and 45-min groups were statistically comparable to those in the ≥ 60-min group. The relative differences between the 30-min and ≥ 60-min groups ranged from 12.3% ± 15.1% for K 1 to 29.8% ± 30.0% for V B , and those between the 45-min and ≥ 60-min groups ranged from 7.5% ± 8.7% for Ki to 24.0% ± 24.3% for V B . However, this comparability was not observed between the 21-min and ≥ 60-min groups. The significance trend of these comparisons remained consistent across different models (reversible or irreversible), administrated activity levels, and partial volume corrections for lesions. Significant correlations in tumor kinetic metrics were identified between the 30-/45-min and ≥ 60-min groups, with Deming regression slopes &gt; 0.813. In addition, the comparability of kinetic metrics between the 30-min and ≥ 60-min groups were established for normal tissues. Conclusion The acquisition time for dynamic PET imaging can be reduced to 30 min without compromising the ability to reveal tumor kinetic metrics of [ 18 F]FDG, using the total-body PET/CT system.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>38078950</pmid><doi>10.1007/s00259-023-06526-4</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7457-876X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1619-7070
ispartof European journal of nuclear medicine and molecular imaging, 2024-04, Vol.51 (5), p.1371-1382
issn 1619-7070
1619-7089
language eng
recordid cdi_proquest_journals_2972958058
source MEDLINE; SpringerLink Journals
subjects Cardiology
Computed tomography
Fluorine isotopes
Fluorodeoxyglucose F18
Glucose
Humans
Imaging
Kinetics
Medical imaging
Medicine
Medicine & Public Health
Neoplasms - diagnostic imaging
Nuclear Medicine
Oncology
Original Article
Orthopedics
Positron emission
Positron emission tomography
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography - methods
Radiology
Tumors
title Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamic%20total-body%20PET/CT%20imaging%20with%20reduced%20acquisition%20time%20shows%20acceptable%20performance%20in%20quantification%20of%20%5B18F%5DFDG%20tumor%20kinetic%20metrics&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Liu,%20Guobing&rft.date=2024-04-01&rft.volume=51&rft.issue=5&rft.spage=1371&rft.epage=1382&rft.pages=1371-1382&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-023-06526-4&rft_dat=%3Cproquest_cross%3E2972958058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2972958058&rft_id=info:pmid/38078950&rfr_iscdi=true